Funding, News and Announcements

BioCanRx is excited to announce the second intake for their rolling, open call process to fund new opportunities in translational cancer immunotherapy research. They are now accepting letters of intent for the following four research programs:

· Clinical Trials Program
· Enabling Studies Program
· Catalyst Program
· Clinical, Social and Economic Impact Program 

The next intake deadline for these letters of intent is July 29, 2016, by 11:59 p.m. ET.

For research program details and more information about the open call application process, please visit the website. This funding opportunity is available to any investigator in a Canadian institution eligible to receive funding from CIHR, NSERC and SSHRC.